Defunct Company
Total Trials
5
As Lead Sponsor
As Collaborator
0
Total Enrollment
85
NCT00044993
Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Feb 28, 2002
Completion: Aug 31, 2004
NCT00116363
Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
Start: Mar 31, 2005
Completion: Dec 31, 2006